Zepbound 5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB26FT0QB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,964
Award facts
- Contract value 100% obligated
- $12,963.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $12,963.86 firm fixed price delivery order to AmerisourceBergen Drug Corp for Zepbound (semaglutide) 5 mg/0.5 mL pen injections on November 5, 2025, with completion expected by November 6, 2025. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was not designated as a set-aside and was competitively awarded. AmerisourceBergen's place of performance is listed as Conshohocken, Pennsylvania, where the company maintains its corporate headquarters.
This contract falls within the Defense Health Agency's pharmaceutical supply operations supporting military and veteran healthcare systems. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for the DLA Medical Supply Chain, providing a comprehensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The Zepbound delivery order reflects the military healthcare system's procurement of contemporary diabetes and weight management medications as part of routine medical supply replenishment. The parent IDC vehicle enables AmerisourceBergen to fulfill federal medical procurement requirements across multiple therapeutic domains and geographic regions, supporting defense and veteran populations globally.
Quick answers
Who was awarded contract SPE2DB26FT0QB?
SPE2DB26FT0QB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DB26FT0QB worth?
The government has obligated $12,964 on SPE2DB26FT0QB.
Is contract SPE2DB26FT0QB an order under another contract?
Yes. SPE2DB26FT0QB is a delivery order under SPE2DB22D3401, an indefinite delivery contract.
Was contract SPE2DB26FT0QB competed?
The extent of competition for SPE2DB26FT0QB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award